The Amyloidosis Channel is supported with funding from Prothena (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2020 | Measurable M-spike before ASCT associated with shorter survival in AL Amyloidosis
Morie Gertz
• 30 Nov 2020
In this video, Morie Gertz, MD, MACP, Mayo Clinic College of Medicine, Rochester, MN, discusses research showing that the presence of a measurable monoclonal spike (M-spike) before autologous stem cell transplantation (ASCT) is associated with shorter survival in patients with light chain (AL) amyloidosis. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.
